News
-
Call Announcement: EP PerMed JTC2027
EP PerMed is launching the Joint Transnational Call 2027 for Cell and Gene Therapy for Personalised Medicine (CGT4PM2027). The call aims to fund projects focusing on the development and validation of innovative and novel cell and gene therapies for personalised medicine. Deadline for pre-proposal submission is 20 January 2027 (14:00, CET). A call information day will be organised…
-
Open Research Europe Relaunches: Open Access Publishing for EP PerMed Projects
Researchers and innovators funded by EP PerMed can publish free of charge on Open Research Europe (ORE). Relaunched on 2 November 2026, the platform offers open access publishing with transparent peer review and a wide choice of article formats.
-
EP PerMed Strengthens International Collaboration Through In-situ Visit to South Africa
From 19 to 23 October 2026, EP PerMed representatives visited Cape Town, South Africa, to explore the country’s growing personalised medicine ecosystem and exchange experiences with local researchers, innovators and funding organisations. Hosted by the South African Medical Research Council (SAMRC), the visit coincided with celebrations marking ten years of precision medicine initiatives in South Africa.
-
New EP PerMed Publication Highlights Five Priorities for Implementing Personalised Medicine in Healthcare
How can personalised medicine move from scientific innovation into routine clinical practice? A new publication by EP PerMed representatives in the European Medical Specialist Review identifies five key areas for action and highlights the importance of multistakeholder collaboration to advance implementation across European healthcare systems.
EP PerMed JTC2027
Cell and Gene Therapy for Personalised Medicine (CGT4PM2027)
The EP PerMed Joint Transnational Call 2027 ‘Cell and Gene Therapy for Personalised Medicine’ (CGT4PM2027) aims to fund projects focusing on the development and validation of innovative and novel cell and gene therapies for personalised medicine.
EP PerMed Stakeholder Forum
Join to move personalised medicine forward!
The EP PerMed Stakeholder Forum brings together researchers, clinicians, companies, patients, regulatory stakeholders, and other key players in personalised medicine (PM) on a single platform to accelerate the translation of research findings into clinical practice and marketable applications.
Showcase your own expertise and interests in personalised medicine, either scientifically or along the value chain for implementation. Find others with exactly the knowledge you need for your next steps or be found by others, who specifically need your advice. You can reach out to potentially interesting partners directly within the platform to initiate a first contact.
Mission & Objectives
EP PerMed Podcast ‘The Science of You’
The second season of the EP PerMed podcast tells four powerful stories of patients and former patients who have benefited from personalised medicine. With topics ranging from oncology and rare genetic disorders to preventive surgery and cardiovascular diseases, this season illustrates real human experiences, showing how tailored therapies are transforming the treatment process into a more effective and informed one.